Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics Many neuropsychiatric conditions, including depression, involve synaptic loss and atrophy of the prefrontal cortex. The rapid regrowth of cortical neurons has been hypothesized to explain the rapid an...

Read the latest research from Delix on #zalsupindole, a compound invented at the #UCDavisIPN by director @deolsonlab.bsky.social and his team. Zalsupindole, is a non-dissociative, non-hallucinogenic #psychedelic analogue, and is the first neuroplastogen to be administered to patients with MDD!